K‑303
Various solid tumors (bevacizumab biosimilar)
Phase 3Active
Key Facts
About Kalbe
Indonesia's top integrated healthcare group driving growth through innovative biologics and broad consumer health portfolio.
View full company profileVarious solid tumors (bevacizumab biosimilar)
Indonesia's top integrated healthcare group driving growth through innovative biologics and broad consumer health portfolio.
View full company profile